Ophthalmology Times

Treating and managing glaucoma in children with Stickler Syndrome

Adam Jacobson, MD, and colleagues retrospectively investigated how glaucoma affects the eyes of pediatric patients with ...

EYLEA HD® (aflibercept) Approved by FDA as First and Only Injectable Anti-VEGF with Dosing Intervals Up to 5 Months for Wet Age-related Macular Degeneration (wAMD) and ...

Approval is based on 96-week data from 2 pivotal trials showing majority of EYLEA HD patients maintained their visual and anatomic improvements ...

Light in the dark: The search for new treatments for hereditary blindness

One night, Tomás realized something was seriously wrong. He went for a stroll, along the same paths near his village that he ...

ANI Pharmaceuticals Announces Publication of NEW DAY Clinical Trial Results in Ophthalmology

ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced publication of the results from the NEW DAY clinical trial involving ILUVIEN ® (fluocinolone acetonide intravitreal ...

European Commission Approves KEYTRUDA® (pembrolizumab) Plus Paclitaxel ± Bevacizumab for the Treatment of Adults With PD-L1 (CPS ≥1) Platinum-Resistant R…

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced that KEYTRUDA® (pembrolizumab), in ...
Nature

This method to reverse cellular ageing is about to be tested in humans

A burgeoning field is launching its first clinical trial to find out whether dialling back cell development can safely ...

Dr. Roach: Explaining birdshot chorioretinopathy and its treatments

My niece was diagnosed with birdshot chorioretinopathy.